

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histone H3-K36 demethylation (GO:0070544) | 4.89006335 |
| 2 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.56440551 |
| 3 | nuclear pore complex assembly (GO:0051292) | 4.51050403 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.37723978 |
| 5 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.12029621 |
| 6 | cellular response to ethanol (GO:0071361) | 4.08577862 |
| 7 | interkinetic nuclear migration (GO:0022027) | 4.05686314 |
| 8 | nuclear pore organization (GO:0006999) | 4.03353361 |
| 9 | histone H3-K4 trimethylation (GO:0080182) | 3.93311775 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.74078697 |
| 11 | establishment of protein localization to Golgi (GO:0072600) | 3.68067403 |
| 12 | histone mRNA catabolic process (GO:0071044) | 3.57553293 |
| 13 | histone H3-K9 demethylation (GO:0033169) | 3.50863798 |
| 14 | dosage compensation (GO:0007549) | 3.50273196 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.38726368 |
| 16 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.34761089 |
| 17 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.33776142 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 3.33336217 |
| 19 | pore complex assembly (GO:0046931) | 3.32542108 |
| 20 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.31521966 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.29257895 |
| 22 | phospholipid translocation (GO:0045332) | 3.28970009 |
| 23 | lipid translocation (GO:0034204) | 3.28970009 |
| 24 | peptidyl-lysine trimethylation (GO:0018023) | 3.28750723 |
| 25 | protein K48-linked deubiquitination (GO:0071108) | 3.28537110 |
| 26 | histone lysine demethylation (GO:0070076) | 3.27851472 |
| 27 | regulation of necroptotic process (GO:0060544) | 3.27396315 |
| 28 | protein targeting to Golgi (GO:0000042) | 3.26109332 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.23060216 |
| 30 | nucleus localization (GO:0051647) | 3.18204181 |
| 31 | positive T cell selection (GO:0043368) | 3.12457880 |
| 32 | histone demethylation (GO:0016577) | 3.10663337 |
| 33 | negative regulation of DNA repair (GO:0045738) | 3.02725515 |
| 34 | nerve growth factor signaling pathway (GO:0038180) | 2.96106135 |
| 35 | hepatocyte apoptotic process (GO:0097284) | 2.92843092 |
| 36 | protein K11-linked deubiquitination (GO:0035871) | 2.92550279 |
| 37 | cellular extravasation (GO:0045123) | 2.92121888 |
| 38 | mitotic sister chromatid cohesion (GO:0007064) | 2.91223242 |
| 39 | negative T cell selection (GO:0043383) | 2.86870161 |
| 40 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.83394432 |
| 41 | establishment of nucleus localization (GO:0040023) | 2.81942379 |
| 42 | neutrophil mediated immunity (GO:0002446) | 2.79930658 |
| 43 | Golgi to endosome transport (GO:0006895) | 2.79919158 |
| 44 | negative thymic T cell selection (GO:0045060) | 2.78684680 |
| 45 | regulation of RNA export from nucleus (GO:0046831) | 2.78082373 |
| 46 | protein targeting to lysosome (GO:0006622) | 2.77828114 |
| 47 | establishment of protein localization to vacuole (GO:0072666) | 2.77828114 |
| 48 | protein targeting to vacuole (GO:0006623) | 2.77828114 |
| 49 | regulation of protein polyubiquitination (GO:1902914) | 2.76372455 |
| 50 | peptidyl-lysine methylation (GO:0018022) | 2.76053763 |
| 51 | pericardium development (GO:0060039) | 2.74834422 |
| 52 | histone H3-K4 methylation (GO:0051568) | 2.73911434 |
| 53 | positive regulation of granulocyte differentiation (GO:0030854) | 2.71084269 |
| 54 | protein demethylation (GO:0006482) | 2.70928372 |
| 55 | protein dealkylation (GO:0008214) | 2.70928372 |
| 56 | oocyte development (GO:0048599) | 2.70149965 |
| 57 | N-terminal protein amino acid acetylation (GO:0006474) | 2.69483393 |
| 58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.67635387 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.67401511 |
| 60 | histone lysine methylation (GO:0034968) | 2.67249408 |
| 61 | histone H3-K9 modification (GO:0061647) | 2.63865116 |
| 62 | positive regulation of developmental pigmentation (GO:0048087) | 2.62896223 |
| 63 | regulation of establishment of cell polarity (GO:2000114) | 2.61687584 |
| 64 | early endosome to late endosome transport (GO:0045022) | 2.61474038 |
| 65 | protein K63-linked deubiquitination (GO:0070536) | 2.60779347 |
| 66 | fibroblast migration (GO:0010761) | 2.59324357 |
| 67 | neural tube formation (GO:0001841) | 2.59169556 |
| 68 | necrotic cell death (GO:0070265) | 2.58629721 |
| 69 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.57148912 |
| 70 | myeloid leukocyte mediated immunity (GO:0002444) | 2.57129567 |
| 71 | striated muscle atrophy (GO:0014891) | 2.56487066 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 2.55993297 |
| 73 | positive regulation of B cell differentiation (GO:0045579) | 2.54850833 |
| 74 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54722816 |
| 75 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.53987485 |
| 76 | negative regulation of cell killing (GO:0031342) | 2.53987485 |
| 77 | microglial cell activation (GO:0001774) | 2.53229464 |
| 78 | I-kappaB phosphorylation (GO:0007252) | 2.51701272 |
| 79 | definitive hemopoiesis (GO:0060216) | 2.50480654 |
| 80 | regulation of fibroblast apoptotic process (GO:2000269) | 2.49301623 |
| 81 | negative regulation of interleukin-12 production (GO:0032695) | 2.49148018 |
| 82 | piRNA metabolic process (GO:0034587) | 2.48841943 |
| 83 | skeletal muscle adaptation (GO:0043501) | 2.47550895 |
| 84 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.47370344 |
| 85 | positive regulation by symbiont of host defense response (GO:0052509) | 2.47189396 |
| 86 | modulation by symbiont of host defense response (GO:0052031) | 2.47189396 |
| 87 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.47189396 |
| 88 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.47189396 |
| 89 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.47189396 |
| 90 | modulation by symbiont of host immune response (GO:0052553) | 2.47189396 |
| 91 | regulation of pigment cell differentiation (GO:0050932) | 2.43789041 |
| 92 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.43538190 |
| 93 | peptidyl-threonine phosphorylation (GO:0018107) | 2.42967032 |
| 94 | histone H3-K9 methylation (GO:0051567) | 2.42318595 |
| 95 | necroptotic process (GO:0070266) | 2.41781249 |
| 96 | programmed necrotic cell death (GO:0097300) | 2.41177286 |
| 97 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.40788947 |
| 98 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.40418087 |
| 99 | sister chromatid cohesion (GO:0007062) | 2.39515512 |
| 100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.36633072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.11799364 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.87027455 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.57992402 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.28277522 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.22165072 |
| 6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.94404040 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73978641 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20805835 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16074096 |
| 10 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.10463347 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.07169086 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03363972 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00060784 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99256309 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.90129569 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.88657763 |
| 17 | TP53_16413492_ChIP-PET_HCT116_Human | 1.87651652 |
| 18 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82470484 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81220093 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80724501 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80664512 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.76537591 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76047385 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74433181 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73528278 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72357039 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68237400 |
| 28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68086182 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.61168880 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57290218 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.56557404 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55232319 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55087570 |
| 34 | STAT3_23295773_ChIP-Seq_U87_Human | 1.54560818 |
| 35 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.53224469 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52999586 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.51707925 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.50181420 |
| 39 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.42241576 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41181365 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39568447 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38836406 |
| 43 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.37507236 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35664670 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35339715 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35187075 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33849729 |
| 48 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32510065 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31350659 |
| 50 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29778712 |
| 51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28746217 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25846197 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24865200 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24737650 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24069399 |
| 56 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22194219 |
| 57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21977999 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21125697 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19924541 |
| 60 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19924541 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.19722491 |
| 62 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19109713 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19016484 |
| 64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18771375 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.18702832 |
| 66 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.17417942 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17192757 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17167838 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16952864 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16409596 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16014468 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15930744 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15920925 |
| 74 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15673194 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15512355 |
| 76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15512355 |
| 77 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.14950429 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14716797 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13908739 |
| 80 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13431946 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11733308 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10978173 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10765965 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10519673 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07779015 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07053495 |
| 87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07053495 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06552098 |
| 89 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05389554 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04932493 |
| 91 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03746084 |
| 92 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.03657413 |
| 93 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.02219467 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00975633 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00685085 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.00579876 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99494758 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99375367 |
| 99 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97342091 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95172469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.46167104 |
| 2 | MP0008057_abnormal_DNA_replication | 5.45015273 |
| 3 | MP0002009_preneoplasia | 3.18408258 |
| 4 | MP0003787_abnormal_imprinting | 2.92036490 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.87703131 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.50262827 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.41398750 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.38887885 |
| 9 | MP0004808_abnormal_hematopoietic_stem | 2.27221214 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.24148089 |
| 11 | MP0003828_pulmonary_edema | 2.10905411 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.06166078 |
| 13 | MP0003045_fibrosis | 2.05036459 |
| 14 | MP0003724_increased_susceptibility_to | 2.02801139 |
| 15 | MP0003303_peritoneal_inflammation | 1.94876222 |
| 16 | MP0003656_abnormal_erythrocyte_physiolo | 1.88274343 |
| 17 | MP0001835_abnormal_antigen_presentation | 1.83551832 |
| 18 | MP0000015_abnormal_ear_pigmentation | 1.82936567 |
| 19 | MP0008877_abnormal_DNA_methylation | 1.80668011 |
| 20 | MP0002332_abnormal_exercise_endurance | 1.79370045 |
| 21 | MP0008260_abnormal_autophagy | 1.76027829 |
| 22 | MP0001800_abnormal_humoral_immune | 1.70600837 |
| 23 | MP0003091_abnormal_cell_migration | 1.64261725 |
| 24 | MP0003950_abnormal_plasma_membrane | 1.61415399 |
| 25 | MP0002006_tumorigenesis | 1.54668311 |
| 26 | MP0005310_abnormal_salivary_gland | 1.44386780 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.41587119 |
| 28 | MP0004381_abnormal_hair_follicle | 1.41572521 |
| 29 | MP0002398_abnormal_bone_marrow | 1.40492248 |
| 30 | MP0003646_muscle_fatigue | 1.38314445 |
| 31 | MP0004484_altered_response_of | 1.37878809 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.36381902 |
| 33 | MP0000685_abnormal_immune_system | 1.35921746 |
| 34 | MP0010307_abnormal_tumor_latency | 1.34906662 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.32794488 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.29513020 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.27021780 |
| 38 | MP0004036_abnormal_muscle_relaxation | 1.25421908 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.24487004 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.24487004 |
| 41 | MP0000427_abnormal_hair_cycle | 1.24154858 |
| 42 | MP0002723_abnormal_immune_serum | 1.24116574 |
| 43 | MP0001819_abnormal_immune_cell | 1.22873118 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.22326452 |
| 45 | MP0009115_abnormal_fat_cell | 1.21732500 |
| 46 | MP0002419_abnormal_innate_immunity | 1.21650024 |
| 47 | MP0002168_other_aberrant_phenotype | 1.20598918 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.19940632 |
| 49 | MP0004130_abnormal_muscle_cell | 1.19721026 |
| 50 | MP0000383_abnormal_hair_follicle | 1.15267771 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.14900125 |
| 52 | MP0000371_diluted_coat_color | 1.14666133 |
| 53 | MP0000716_abnormal_immune_system | 1.14417622 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 1.14292709 |
| 55 | MP0005451_abnormal_body_composition | 1.12752453 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.11111827 |
| 57 | MP0005266_abnormal_metabolism | 1.08725695 |
| 58 | MP0003868_abnormal_feces_composition | 1.07583723 |
| 59 | MP0002722_abnormal_immune_system | 1.06594156 |
| 60 | MP0001790_abnormal_immune_system | 1.06028196 |
| 61 | MP0005387_immune_system_phenotype | 1.06028196 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.01413815 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.01403967 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.01401236 |
| 65 | MP0002405_respiratory_system_inflammati | 1.01194435 |
| 66 | MP0004233_abnormal_muscle_weight | 0.99976249 |
| 67 | MP0002998_abnormal_bone_remodeling | 0.98472028 |
| 68 | MP0005621_abnormal_cell_physiology | 0.97723065 |
| 69 | MP0005164_abnormal_response_to | 0.97400215 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 0.95716822 |
| 71 | MP0001915_intracranial_hemorrhage | 0.95653193 |
| 72 | MP0006054_spinal_hemorrhage | 0.94836172 |
| 73 | MP0005409_darkened_coat_color | 0.94053320 |
| 74 | MP0008004_abnormal_stomach_pH | 0.93612968 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.93545114 |
| 76 | MP0005671_abnormal_response_to | 0.93527949 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 0.91391698 |
| 78 | MP0001851_eye_inflammation | 0.88741318 |
| 79 | MP0004947_skin_inflammation | 0.88513389 |
| 80 | MP0003252_abnormal_bile_duct | 0.86651010 |
| 81 | MP0005025_abnormal_response_to | 0.85612328 |
| 82 | MP0004883_abnormal_blood_vessel | 0.85557628 |
| 83 | MP0003690_abnormal_glial_cell | 0.85064625 |
| 84 | MP0002429_abnormal_blood_cell | 0.84185406 |
| 85 | MP0002928_abnormal_bile_duct | 0.81595244 |
| 86 | MP0003436_decreased_susceptibility_to | 0.81073998 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.80948896 |
| 88 | MP0010155_abnormal_intestine_physiology | 0.80453000 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.79343792 |
| 90 | MP0003121_genomic_imprinting | 0.78280320 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 0.77747916 |
| 92 | MP0005395_other_phenotype | 0.76457485 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.76296416 |
| 94 | MP0003866_abnormal_defecation | 0.75820164 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 0.72024140 |
| 96 | MP0003890_abnormal_embryonic-extraembry | 0.71720759 |
| 97 | MP0006082_CNS_inflammation | 0.70255902 |
| 98 | MP0005275_abnormal_skin_tensile | 0.69405726 |
| 99 | MP0005384_cellular_phenotype | 0.67866078 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.65440032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Heterotopia (HP:0002282) | 3.51431697 |
| 2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.41416902 |
| 3 | T lymphocytopenia (HP:0005403) | 3.36919173 |
| 4 | Truncal obesity (HP:0001956) | 3.34720160 |
| 5 | Abnormality of the fingertips (HP:0001211) | 3.31614747 |
| 6 | Papillary thyroid carcinoma (HP:0002895) | 3.24294195 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.16321977 |
| 8 | Chronic hepatic failure (HP:0100626) | 2.96571217 |
| 9 | Menstrual irregularities (HP:0000858) | 2.87672464 |
| 10 | Subacute progressive viral hepatitis (HP:0006572) | 2.75888489 |
| 11 | Prominent nose (HP:0000448) | 2.69877603 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 2.69660227 |
| 13 | Acute myeloid leukemia (HP:0004808) | 2.59257462 |
| 14 | Hematochezia (HP:0002573) | 2.58989422 |
| 15 | Fair hair (HP:0002286) | 2.54912394 |
| 16 | Autoimmune hemolytic anemia (HP:0001890) | 2.53500955 |
| 17 | Eczematoid dermatitis (HP:0000976) | 2.53491204 |
| 18 | Spontaneous hematomas (HP:0007420) | 2.53362838 |
| 19 | Narrow palate (HP:0000189) | 2.53225116 |
| 20 | Volvulus (HP:0002580) | 2.47380683 |
| 21 | Protruding tongue (HP:0010808) | 2.46936025 |
| 22 | Sandal gap (HP:0001852) | 2.44593713 |
| 23 | Submucous cleft hard palate (HP:0000176) | 2.39259677 |
| 24 | Difficulty running (HP:0009046) | 2.34530995 |
| 25 | Thyroiditis (HP:0100646) | 2.32052451 |
| 26 | Spondylolisthesis (HP:0003302) | 2.31797095 |
| 27 | Gingival bleeding (HP:0000225) | 2.31567031 |
| 28 | Deep philtrum (HP:0002002) | 2.31341445 |
| 29 | Hypoplastic iliac wings (HP:0002866) | 2.29974907 |
| 30 | Overgrowth (HP:0001548) | 2.29875830 |
| 31 | Dysmetric saccades (HP:0000641) | 2.26379617 |
| 32 | Absent frontal sinuses (HP:0002688) | 2.24356825 |
| 33 | Recurrent abscess formation (HP:0002722) | 2.23770470 |
| 34 | Gingivitis (HP:0000230) | 2.23495568 |
| 35 | Genetic anticipation (HP:0003743) | 2.22949949 |
| 36 | Curly hair (HP:0002212) | 2.22623334 |
| 37 | Cystic hygroma (HP:0000476) | 2.21685683 |
| 38 | Generalized hypopigmentation of hair (HP:0011358) | 2.20272258 |
| 39 | Lip pit (HP:0100267) | 2.14569113 |
| 40 | Widely spaced teeth (HP:0000687) | 2.10222931 |
| 41 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.10197401 |
| 42 | Portal hypertension (HP:0001409) | 2.07912952 |
| 43 | Colitis (HP:0002583) | 2.07157179 |
| 44 | Chest pain (HP:0100749) | 2.03738728 |
| 45 | Recurrent viral infections (HP:0004429) | 2.03194991 |
| 46 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.03075136 |
| 47 | Viral hepatitis (HP:0006562) | 2.01880253 |
| 48 | Cubitus valgus (HP:0002967) | 2.00099651 |
| 49 | Recurrent fungal infections (HP:0002841) | 1.98914989 |
| 50 | Broad face (HP:0000283) | 1.96751859 |
| 51 | Neonatal hypoglycemia (HP:0001998) | 1.96595588 |
| 52 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.95479514 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.95458402 |
| 54 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.94852308 |
| 55 | Aortic aneurysm (HP:0004942) | 1.94462061 |
| 56 | Conjunctival telangiectasia (HP:0000524) | 1.93331905 |
| 57 | Arterial thrombosis (HP:0004420) | 1.89698621 |
| 58 | Amaurosis fugax (HP:0100576) | 1.87302419 |
| 59 | Gaze-evoked nystagmus (HP:0000640) | 1.87279365 |
| 60 | Tapered finger (HP:0001182) | 1.87077174 |
| 61 | Autoimmune thrombocytopenia (HP:0001973) | 1.85272288 |
| 62 | Thickened calvaria (HP:0002684) | 1.85197494 |
| 63 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.84906688 |
| 64 | Anhidrosis (HP:0000970) | 1.83194991 |
| 65 | Abnormality of the hepatic vasculature (HP:0006707) | 1.81016354 |
| 66 | Hyperventilation (HP:0002883) | 1.80974213 |
| 67 | Hyperkalemia (HP:0002153) | 1.79982498 |
| 68 | Fatigue (HP:0012378) | 1.79670563 |
| 69 | Thyroid carcinoma (HP:0002890) | 1.79603587 |
| 70 | Subaortic stenosis (HP:0001682) | 1.78521600 |
| 71 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.78521600 |
| 72 | Periodontitis (HP:0000704) | 1.77628196 |
| 73 | Low anterior hairline (HP:0000294) | 1.76126497 |
| 74 | Tubulointerstitial nephritis (HP:0001970) | 1.76103445 |
| 75 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74831041 |
| 76 | Long eyelashes (HP:0000527) | 1.74677721 |
| 77 | Neoplasm of the oral cavity (HP:0100649) | 1.73935289 |
| 78 | Macroorchidism (HP:0000053) | 1.73641565 |
| 79 | Increased number of teeth (HP:0011069) | 1.72209886 |
| 80 | Rhabdomyosarcoma (HP:0002859) | 1.69850412 |
| 81 | Coarse hair (HP:0002208) | 1.68439316 |
| 82 | Dislocated radial head (HP:0003083) | 1.67889832 |
| 83 | Syringomyelia (HP:0003396) | 1.67883494 |
| 84 | Spinal cord lesions (HP:0100561) | 1.67883494 |
| 85 | Chronic diarrhea (HP:0002028) | 1.66526432 |
| 86 | Bladder neoplasm (HP:0009725) | 1.65529473 |
| 87 | Bladder carcinoma (HP:0002862) | 1.65529473 |
| 88 | Abnormal hair whorl (HP:0010721) | 1.65511492 |
| 89 | Abnormality of the wing of the ilium (HP:0011867) | 1.65381281 |
| 90 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.65096537 |
| 91 | Resting tremor (HP:0002322) | 1.65009263 |
| 92 | Short chin (HP:0000331) | 1.64453746 |
| 93 | Osteolytic defects of the hand bones (HP:0009699) | 1.64065347 |
| 94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.64065347 |
| 95 | Capillary hemangiomas (HP:0005306) | 1.64015545 |
| 96 | IgA deficiency (HP:0002720) | 1.63727846 |
| 97 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.62685526 |
| 98 | Relative macrocephaly (HP:0004482) | 1.62479229 |
| 99 | Inflammation of the large intestine (HP:0002037) | 1.59925870 |
| 100 | Large earlobe (HP:0009748) | 1.59826306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 3.52615489 |
| 2 | FRK | 3.42632235 |
| 3 | CDK12 | 2.98597939 |
| 4 | SGK2 | 2.24112284 |
| 5 | ACVR1B | 2.23998970 |
| 6 | BLK | 2.21812834 |
| 7 | MAP3K13 | 2.21232200 |
| 8 | CAMK1G | 2.20070943 |
| 9 | PIK3CG | 2.18017920 |
| 10 | BRD4 | 2.10215385 |
| 11 | CAMK1D | 1.98166286 |
| 12 | TAOK3 | 1.89039377 |
| 13 | MELK | 1.82317431 |
| 14 | WNK1 | 1.76724712 |
| 15 | TGFBR2 | 1.76310802 |
| 16 | SGK3 | 1.71404935 |
| 17 | TRPM7 | 1.65913995 |
| 18 | MAP3K7 | 1.64764280 |
| 19 | MAP3K14 | 1.63597270 |
| 20 | TEC | 1.60361995 |
| 21 | NLK | 1.60048000 |
| 22 | JAK1 | 1.49385333 |
| 23 | IKBKE | 1.45967801 |
| 24 | FGFR3 | 1.41691334 |
| 25 | NEK9 | 1.36360637 |
| 26 | CAMKK2 | 1.33177652 |
| 27 | BTK | 1.31710033 |
| 28 | RIPK4 | 1.28688586 |
| 29 | EIF2AK3 | 1.28092176 |
| 30 | MARK2 | 1.16581702 |
| 31 | SGK223 | 1.15780465 |
| 32 | SGK494 | 1.15780465 |
| 33 | HCK | 1.08808029 |
| 34 | EPHA3 | 1.07579252 |
| 35 | TTN | 1.07399321 |
| 36 | JAK3 | 1.04589362 |
| 37 | MAP2K3 | 1.02548998 |
| 38 | SYK | 1.02077587 |
| 39 | IRAK4 | 0.97993047 |
| 40 | PIK3CA | 0.97909664 |
| 41 | OBSCN | 0.97294891 |
| 42 | IRAK1 | 0.95686880 |
| 43 | PRKAA2 | 0.95585749 |
| 44 | BMPR2 | 0.94407419 |
| 45 | ZAP70 | 0.93885630 |
| 46 | MAP3K2 | 0.93579455 |
| 47 | CHUK | 0.92432501 |
| 48 | CSK | 0.90461735 |
| 49 | CAMK4 | 0.87462111 |
| 50 | MAP3K6 | 0.86901677 |
| 51 | NEK6 | 0.86461191 |
| 52 | MAP3K5 | 0.85901901 |
| 53 | FGR | 0.82444535 |
| 54 | MAP4K1 | 0.81262584 |
| 55 | JAK2 | 0.81192197 |
| 56 | RPS6KB1 | 0.80771134 |
| 57 | FES | 0.79034182 |
| 58 | ITK | 0.78658004 |
| 59 | RAF1 | 0.77862913 |
| 60 | PDK1 | 0.77701501 |
| 61 | TYK2 | 0.77474685 |
| 62 | PDGFRB | 0.76360666 |
| 63 | LCK | 0.76030276 |
| 64 | PIM1 | 0.75877097 |
| 65 | MAP3K4 | 0.72536156 |
| 66 | SGK1 | 0.71329218 |
| 67 | STK38 | 0.70030618 |
| 68 | CDK9 | 0.68169234 |
| 69 | RET | 0.66948630 |
| 70 | MARK3 | 0.64988421 |
| 71 | MAP3K1 | 0.64723638 |
| 72 | MAP2K4 | 0.62906865 |
| 73 | KSR1 | 0.62475864 |
| 74 | IKBKB | 0.62287030 |
| 75 | NUAK1 | 0.62171291 |
| 76 | STK11 | 0.61409501 |
| 77 | TXK | 0.58923067 |
| 78 | PTK2B | 0.58732414 |
| 79 | MAPK11 | 0.58049539 |
| 80 | LYN | 0.57796013 |
| 81 | MTOR | 0.57418212 |
| 82 | LATS1 | 0.56403152 |
| 83 | BMPR1B | 0.55284995 |
| 84 | CDC42BPA | 0.52772342 |
| 85 | CDK6 | 0.51343294 |
| 86 | RPS6KB2 | 0.51193643 |
| 87 | KSR2 | 0.50400178 |
| 88 | PRPF4B | 0.48150192 |
| 89 | PNCK | 0.47625906 |
| 90 | MAPK7 | 0.46649254 |
| 91 | YES1 | 0.45588867 |
| 92 | PLK2 | 0.45567723 |
| 93 | BRSK2 | 0.45490213 |
| 94 | CSF1R | 0.45279919 |
| 95 | STK10 | 0.44676731 |
| 96 | FER | 0.43571778 |
| 97 | STK4 | 0.43566460 |
| 98 | EGFR | 0.42582629 |
| 99 | EEF2K | 0.41561345 |
| 100 | MAPK10 | 0.41223758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.39714823 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04847967 |
| 3 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.74765701 |
| 4 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.74251665 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68677559 |
| 6 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.66810049 |
| 7 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.61473129 |
| 8 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.59419324 |
| 9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58132820 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.56182953 |
| 11 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.56016840 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.51027279 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48386271 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43896590 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42894529 |
| 16 | Endometrial cancer_Homo sapiens_hsa05213 | 1.39458806 |
| 17 | Platelet activation_Homo sapiens_hsa04611 | 1.37120144 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35931498 |
| 19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34813955 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.33186663 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31369705 |
| 22 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.31189430 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31168844 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.30509267 |
| 25 | Colorectal cancer_Homo sapiens_hsa05210 | 1.30339398 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30317891 |
| 27 | Prostate cancer_Homo sapiens_hsa05215 | 1.26600566 |
| 28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26052354 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21151302 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19417097 |
| 31 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19021229 |
| 32 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.18646736 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.16395971 |
| 34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14475362 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.13041832 |
| 36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.10612458 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10110245 |
| 38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06364812 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04395931 |
| 40 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04090826 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03053073 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 1.03037420 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.02692979 |
| 44 | Insulin resistance_Homo sapiens_hsa04931 | 1.02573096 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01373249 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.00530138 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98744450 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 0.98020547 |
| 49 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97785244 |
| 50 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.96700056 |
| 51 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93449700 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92834551 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88371431 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.88317228 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88243276 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88224605 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87545989 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86875988 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86142304 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84616114 |
| 61 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83698496 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82572882 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80518488 |
| 64 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.78641795 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78022141 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77509367 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.76781665 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.75952265 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75917078 |
| 70 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75844549 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.73820124 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73070016 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72662270 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.72638875 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.72502069 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71552244 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71148921 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70956899 |
| 79 | Long-term depression_Homo sapiens_hsa04730 | 0.70175871 |
| 80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69749740 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66939986 |
| 82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66811286 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66725148 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.66616582 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64978280 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64614621 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63662988 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61031035 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59575096 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58697969 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58449062 |
| 92 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58227316 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55679635 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.55082760 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.54401544 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53627776 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.51565132 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50963376 |
| 99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50474356 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.49245303 |

